Table 4.
Relation between the presence of BCG scar with coronavirus disease 2019 frequency and severity in patients with or without comorbidity
| COVID-19 history | COVID-19-related hospitalization | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No | Yes | No | Yes | ||||||||
| Comorbidity | n | % | n | % | P | n | % | n | % | P | |
| No | BCG Scar | ||||||||||
| 0 | 21 | 15.2 | 20 | 19.0 | 15 | 16.7 | 5 | 33.3 | |||
| 1 | 89 | 64.5 | 69 | 64.8 | 62 | 68.9 | 6 | 40.0 | |||
| ≥2 | 28 | 20.3 | 17 | 16.2 | .589* | 13 | 14.4 | 4 | 26.7 | .095* | |
| Yes | BCG Scar | ||||||||||
| 0 | 14 | 18.9 | 18 | 21.7 | 11 | 19.6 | 7 | 25.9 | |||
| 1 | 48 | 64.9 | 49 | 59.0 | 33 | 58.9 | 16 | 59.3 | |||
| ≥2 | 12 | 16.2 | 16 | 19.3 | .753* | 12 | 21.4 | 4 | 14.8 | .689* | |
BCG = Bacille Calmette–Guerin, COVID-19 = coronavirüs disease 2019.
*
Chi-square test.